Pressure BioSciences, Inc.
PBIO
$0.0031
-$0.002-39.22%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.86% | 18.47% | -75.91% | 18.67% | -0.95% |
| Total Depreciation and Amortization | 18.34% | 169.75% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.21% | -20.77% | 66.09% | -20.18% | -8.79% |
| Change in Net Operating Assets | 145.67% | -62.92% | 155.77% | -9.83% | 12.13% |
| Cash from Operations | 62.04% | -64.25% | -54.59% | 18.55% | -112.98% |
| Capital Expenditure | -- | -- | 100.00% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -- | 100.00% |
| Total Debt Issued | -51.65% | 31.15% | 70.11% | -55.60% | -30.45% |
| Total Debt Repaid | 20.70% | 7.81% | -74.26% | 82.24% | 41.30% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -72.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -59.76% | 47.45% | 68.46% | 4.69% | 3.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.08% | -202.76% | 485.79% | 90.79% | -190.99% |